CABA
Cabaletta Bio Inc
2.20$
-11.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +46.4% | -5.2% | -9.6% | -6.0% | -9.5% | -10.8% | +35.9% | -15.5% | -13.0% | -10.3% | +73.3% | |
| – | +47.1% | -7.0% | -9.3% | -10.1% | -10.2% | -19.2% | +47.4% | -17.1% | -15.6% | -11.9% | +88.9% | |
| – | +67.3% | -9.3% | +1.9% | -4.5% | -3.9% | -19.6% | +10.5% | -58.7% | +37.8% | +40.6% | +93.0% | |
| – | +46.8% | -7.2% | -9.2% | -9.9% | -10.4% | -19.6% | +47.7% | -17.9% | -16.5% | -12.7% | +93.0% | |
| – | +41.2% | +7.4% | -4.5% | +68.6% | +8.4% | +33.3% | +5.6% | +9.3% | +5.4% | -15.4% | +2.9% | |
| – | +50.7% | +12.4% | -0.4% | +27.8% | +18.4% | +25.5% | +22.2% | +10.1% | +9.7% | -17.2% | -3.8% | |
| – | +41.2% | +108.0% | -0.1% | +7.3% | +25.7% | +92.4% | +6.4% | +4.0% | +14.1% | -4.6% | -15.7% | |
| – | +25.6% | +28.5% | -27.8% | -48.3% | +125.8% | +31.9% | +10.8% | +14.9% | -19.7% | -3.8% | -8.9% | |
| – | +46.8% | -6.1% | -10.0% | -12.7% | -12.6% | -20.2% | +46.8% | -21.9% | -19.7% | -7.8% | +103.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.1% | +11.0% | +0.3% | +0.1% | +1.5% | -1.4% | +25.1% | +65.3% | +0.0% | +9.5% | +34.9% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.